A three-dimensional product may be created layer by layer from digital designs using threedimensional printing (3DP). 3DP employs programming and computer-aided drafting technologies to produce three-dimensional objects by depositing material in layers onto a substrate one after another to reliably dispense modest amounts of medication along with fine spatial control for individualized drug administration. The 3DP technology is being extensively researched in the field of medicine delivery after the FDA approved the first 3D printed tablet of levetiracetam sold under the brand name Spritam. The pharmaceutical sector has used a variety of 3DP methodologies during the past 15 years including Inkjet printing systems, Nozzle-based deposition systems, and Laser writing systems